HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexey A Leontovich Selected Research

Hematologic Neoplasms (Hematological Malignancy)

10/2018Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexey A Leontovich Research Topics

Disease

21Neoplasms (Cancer)
04/2021 - 02/2004
9Melanoma (Melanoma, Malignant)
04/2021 - 03/2009
4Inflammation (Inflammations)
08/2015 - 01/2007
3Breast Neoplasms (Breast Cancer)
01/2018 - 06/2012
3Neoplasm Metastasis (Metastasis)
01/2018 - 06/2012
2Intestinal Carcinoid Tumors
03/2010 - 01/2007
2Carcinoid Tumor (Carcinoid)
03/2010 - 01/2007
2Pituitary Neoplasms (Pituitary Adenoma)
02/2008 - 06/2006
1Hyperglycemia
01/2019
1Glioblastoma (Glioblastoma Multiforme)
10/2018
1Hematologic Neoplasms (Hematological Malignancy)
10/2018
1Infections
10/2018
1Triple Negative Breast Neoplasms
01/2018
1Diabetes Complications
12/2015
1Nevus (Nevi)
08/2015
1Nephrotic Syndrome (Syndrome, Nephrotic)
05/2014
1Diabetes Mellitus
03/2013
1Prostatic Neoplasms (Prostate Cancer)
07/2012
1Adenocarcinoma of Lung
01/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012
1Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2010
1Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
02/2009
1Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
02/2009
1Hyperparathyroidism
11/2008
1Osteitis
11/2008
1Fibrosis (Cirrhosis)
11/2008
1Primary Myelofibrosis (Myelosclerosis)
11/2008
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2007
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2007

Drug/Important Bio-Agent (IBA)

8CytokinesIBA
04/2021 - 03/2009
7Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2005
4Biomarkers (Surrogate Marker)IBA
04/2021 - 03/2010
4RNA (Ribonucleic Acid)IBA
10/2018 - 07/2004
3ChemokinesIBA
01/2018 - 05/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 03/2009
2Biological ProductsIBA
04/2021 - 01/2019
2Aurora Kinase AIBA
01/2018 - 05/2013
2Bevacizumab (Avastin)FDA Link
01/2017 - 05/2013
2Carboplatin (JM8)FDA LinkGeneric
01/2017 - 05/2013
2Monoclonal AntibodiesIBA
01/2017 - 05/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013 - 04/2011
2Temozolomide (Temodar)FDA LinkGeneric
11/2012 - 01/2012
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2012 - 11/2008
2OligonucleotidesIBA
01/2007 - 06/2006
1Interleukin-8 (Interleukin 8)IBA
04/2021
1Immune Checkpoint InhibitorsIBA
04/2021
1Insulin (Novolin)FDA Link
01/2019
1Janus Kinase InhibitorsIBA
10/2018
1InterferonsIBA
10/2018
1ruxolitinibIBA
10/2018
1MitogensIBA
01/2018
1Protein Kinases (Protein Kinase)IBA
01/2018
1Estrogen Receptor alphaIBA
01/2018
1Phenobarbital (Luminal)FDA Link
01/2018
1Notch ReceptorsIBA
01/2018
1ClaudinsIBA
01/2018
1Gonadal Steroid Hormones (Sex Hormones)IBA
10/2017
1Paclitaxel (Taxol)FDA LinkGeneric
01/2017
1AntigensIBA
01/2017
1Interleukin-2 (IL2)IBA
01/2017
1MucinsIBA
10/2016
1Immunoglobulins (Immunoglobulin)IBA
10/2016
1TRPC6 Cation ChannelIBA
05/2014
1nephrinIBA
05/2014
1Complement System Proteins (Complement)IBA
05/2014
1Peptide Hydrolases (Proteases)FDA Link
05/2014
1Phospholipase A2 ReceptorsIBA
05/2014
1Cyclin AIBA
05/2013
1Albumin-Bound PaclitaxelFDA Link
05/2013
1Streptozocin (Streptozotocin)FDA Link
03/2013
1Vascular Endothelial Growth Factor CIBA
01/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2012
1Transcription Factors (Transcription Factor)IBA
06/2012
1C-Reactive ProteinIBA
01/2012
1Protein Isoforms (Isoforms)IBA
01/2012
1NucleotidesIBA
01/2012
1MicroRNAs (MicroRNA)IBA
03/2010
1Interleukin-13IBA
03/2009
1InterleukinsIBA
03/2009
1Interleukin-5 (Interleukin 5)IBA
03/2009
1Interleukin-10 (Interleukin 10)IBA
03/2009
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
02/2009
1polycystic kidney disease 1 proteinIBA
02/2009
1polycystic kidney disease 2 proteinIBA
02/2009
1Phosphatidylinositols (Phosphatidylinositol)IBA
11/2008
1AminopropionitrileIBA
11/2008
1WortmanninIBA
11/2008
1Imatinib Mesylate (Gleevec)FDA Link
11/2008
1platelet-derived growth factor AIBA
11/2008
1Transforming Growth Factor beta (TGF-beta)IBA
02/2008
1altersolanol AIBA
04/2007
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2007
1Tumor Viral Antigens (Large T Antigen)IBA
01/2007
1Galectin 3 (LGALS3)IBA
06/2006

Therapy/Procedure

6Therapeutics
04/2021 - 01/2012
6Drug Therapy (Chemotherapy)
01/2017 - 01/2012
2Immunotherapy
08/2015 - 03/2009
1Injections
01/2021
1Oncolytic Virotherapy
10/2018
1Glycemic Control
12/2015